247 related articles for article (PubMed ID: 28862765)
21. Application of failure mode and effects analysis to intracranial stereotactic radiation surgery by linear accelerator.
Masini L; Donis L; Loi G; Mones E; Molina E; Bolchini C; Krengli M
Pract Radiat Oncol; 2014; 4(6):392-7. PubMed ID: 25407860
[TBL] [Abstract][Full Text] [Related]
22. Survey results of 3D-CRT and IMRT quality assurance practice.
Mehrens H; Taylor P; Followill DS; Kry SF
J Appl Clin Med Phys; 2020 Jul; 21(7):70-76. PubMed ID: 32351006
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis.
Ford EC; Gaudette R; Myers L; Vanderver B; Engineer L; Zellars R; Song DY; Wong J; Deweese TL
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):852-8. PubMed ID: 19409731
[TBL] [Abstract][Full Text] [Related]
24. A comparison of two prospective risk analysis methods: Traditional FMEA and a modified healthcare FMEA.
Rah JE; Manger RP; Yock AD; Kim GY
Med Phys; 2016 Dec; 43(12):6347. PubMed ID: 27908165
[TBL] [Abstract][Full Text] [Related]
25. Evaluating radiotherapy treatment delay using Failure Mode and Effects Analysis (FMEA).
Xu Z; Lee S; Albani D; Dobbins D; Ellis RJ; Biswas T; Machtay M; Podder TK
Radiother Oncol; 2019 Aug; 137():102-109. PubMed ID: 31082631
[TBL] [Abstract][Full Text] [Related]
26. Failure mode and effect analysis-based quality assurance for dynamic MLC tracking systems.
Sawant A; Dieterich S; Svatos M; Keall P
Med Phys; 2010 Dec; 37(12):6466-79. PubMed ID: 21302802
[TBL] [Abstract][Full Text] [Related]
27. Improving the treatment planning and delivery process of Xoft electronic skin brachytherapy.
Manger R; Rahn D; Hoisak J; Dragojević I
Brachytherapy; 2018; 17(4):702-708. PubMed ID: 29773330
[TBL] [Abstract][Full Text] [Related]
28. Quantifying clinical severity of physics errors in high-dose rate prostate brachytherapy using simulations.
Nunez DA; Trager M; Beaudry J; Cohen GN; Dauer LT; Gorovets D; Hassan Rezaeian N; Kollmeier MA; Leong B; McCann P; Williamson M; Zelefsky MJ; Damato AL
Brachytherapy; 2021; 20(5):1062-1069. PubMed ID: 34193362
[TBL] [Abstract][Full Text] [Related]
29. Preventing blood transfusion failures: FMEA, an effective assessment method.
Najafpour Z; Hasoumi M; Behzadi F; Mohamadi E; Jafary M; Saeedi M
BMC Health Serv Res; 2017 Jun; 17(1):453. PubMed ID: 28666439
[TBL] [Abstract][Full Text] [Related]
30. Benchmarking failure mode and effects analysis of electronic brachytherapy with data from incident learning systems.
Hoisak JDP; Manger R; Dragojević I
Brachytherapy; 2021; 20(3):645-654. PubMed ID: 33353846
[TBL] [Abstract][Full Text] [Related]
31. Comparison of failure modes and effects analyses and time for brachytherapy ring and tandem applicator digitization between manual and solid applicator source placement methods.
Holtman AL; DiCostanzo DJ; Zimmerman CA; Graeper G; Woollard J; Christ DF; Cetnar AJ
J Appl Clin Med Phys; 2024 May; 25(5):e14336. PubMed ID: 38664983
[TBL] [Abstract][Full Text] [Related]
32. Using failure mode and effects analysis (FMEA) to generate an initial plan check checklist for improved safety in radiation treatment.
Rassiah P; Su FF; Huang YJ; Spitznagel D; Sarkar V; Szegedi MW; Zhao H; Paxton AB; Nelson G; Salter BJ
J Appl Clin Med Phys; 2020 Aug; 21(8):83-91. PubMed ID: 32583912
[TBL] [Abstract][Full Text] [Related]
33. Failure modes and effects analysis for ocular brachytherapy.
Lee YC; Kim Y; Huynh JW; Hamilton RJ
Brachytherapy; 2017; 16(6):1265-1279. PubMed ID: 28827007
[TBL] [Abstract][Full Text] [Related]
34. Practical implementation of failure mode and effects analysis for safety and efficiency in stereotactic radiosurgery.
Younge KC; Wang Y; Thompson J; Giovinazzo J; Finlay M; Sankreacha R
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1003-8. PubMed ID: 25670543
[TBL] [Abstract][Full Text] [Related]
35. Failure mode and effects analysis of linac-based liver stereotactic body radiotherapy.
Rusu I; Thomas TO; Roeske JC; Mescioglu I; Melian E; Surucu M
Med Phys; 2020 Mar; 47(3):937-947. PubMed ID: 31837024
[TBL] [Abstract][Full Text] [Related]
36. Risk analysis by FMEA as an element of analytical validation.
van Leeuwen JF; Nauta MJ; de Kaste D; Odekerken-Rombouts YM; Oldenhof MT; Vredenbregt MJ; Barends DM
J Pharm Biomed Anal; 2009 Dec; 50(5):1085-7. PubMed ID: 19640668
[TBL] [Abstract][Full Text] [Related]
37. Failure mode and effect analysis applied to improve the medication management process in a pharmacy of a teaching hospital and a proposal for a simplified rating system.
Abbassi A; Ben Cheikh Brahim A; Ouahchi Z
Eur J Hosp Pharm; 2023 Mar; 30(e1):e55-e60. PubMed ID: 35064019
[TBL] [Abstract][Full Text] [Related]
38. Failure modes and effects analysis for surface-guided DIBH breast radiotherapy.
Bright M; Foster RD; Hampton CJ; Ruiz J; Moeller B
J Appl Clin Med Phys; 2022 Apr; 23(4):e13541. PubMed ID: 35112445
[TBL] [Abstract][Full Text] [Related]
39. A streamlined failure mode and effects analysis.
Ford EC; Smith K; Terezakis S; Croog V; Gollamudi S; Gage I; Keck J; DeWeese T; Sibley G
Med Phys; 2014 Jun; 41(6):061709. PubMed ID: 24877804
[TBL] [Abstract][Full Text] [Related]
40. A novel risk analysis of clinical reference dosimetry based on failure modes and effects analysis.
Ochi Y; Saito A; Kawahara D; Suzuki T; Tsuneda M; Tanaka S; Nishio T; Ozawa S; Murakami Y; Nagata Y
Phys Med; 2019 Feb; 58():59-65. PubMed ID: 30824151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
